Dual-Drug Stent with Sirolimus and WKYMVm Promotes Endothelialization and Limits Hyperplasia

Key Points

• Endothelialization is significantly improved with the dual-drug stent, indicating better vascular healing.
• A marked reduction in hyperplasia is noted, with up to 30% less tissue growth compared to single-drug options.
• Analysis involves a comparative evaluation of different stent types in relevant animal models, revealing key insights into stent effectiveness.
• This approach may enable better long-term outcomes in patients, but requires further validation through clinical studies.